Report

Product-to-Parent Reversion of Trenbolone: Unrecognized Risks for Endocrine Disruption

See allHide authors and affiliations

Science  18 Oct 2013:
Vol. 342, Issue 6156, pp. 347-351
DOI: 10.1126/science.1243192

You are currently viewing the .

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution